This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Biontech Se, Tron—translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Ggmbh. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 74 
1 out of 16 Years Active: 2022-2026
Title: Innovations by Inventor Stephanie Fesser
Introduction
Stephanie Fesser, based in Mannheim, Germany, is a notable inventor recognized for her significant contributions to the field of RNA technology. With two patents to her name, her work is pivotal in advancing pharmaceutical applications and enhancing RNA stability and translation efficiency.
Latest Patents
Stephanie's latest patents reflect her expertise in in vitro transcription technologies. The first patent outlines technologies for in vitro transcription reactions that focus on the production of pharmaceutical-grade RNA, with the potential for large-scale production. The second patent is centered on 3'-UTR sequences that contribute to the stabilization of RNA, particularly mRNA, leading to improved translation efficiency. This invention highlights the modification of RNA to achieve increased transcript stability and enhances the efficacy of mRNA in various applications.
Career Highlights
Throughout her career, Stephanie Fesser has made significant strides in the biotechnology arena. She has worked with renowned companies, including BioNTech SE, a leader in mRNA-based therapies, and TRON—Translationale Onkologie an Der Universitätsmedizin Der Johannes Gutenberg-Universität Mainz GmbH, where she has contributed her expertise in RNA technology and its therapeutic applications.
Collaborations
Stephanie has collaborated with esteemed colleagues such as Andreas Kuhn and Irena Rabe. These partnerships have enabled her to further her research and innovation in the field of biotechnology, fostering an environment of collaboration that drives advancement in RNA technologies.
Conclusion
In summary, Stephanie Fesser’s inventive work stands as a testament to her dedication to improving RNA technology. Her contributions have not only helped shape the future of pharmaceutical applications but also underscore the importance of innovation in the biotechnology industry. As she continues to develop new solutions, her impact on drug development and therapeutic strategies will undoubtedly be felt for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile